Financing Cash Flow

-$4.65B

TTM · Period ending: Jun 30, 2026 · USD

REGN Financing Cash Flow

Latest reported-$4.65Bperiod endingJun 30, 2026

REGN TTM Cash from Financing (-$800.00K → -$4.65B)

TTM financing cash flow

High-resolution chart · PNG

REGN financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period ending	Financing Cash Flow (USD)
Jun 30, 2026	-4,645,000,000
Mar 31, 2026	-3,428,400,000
Dec 31, 2025	-3,715,400,000
Sep 30, 2025	-4,070,800,000
Jun 30, 2025	-3,986,900,000
Mar 31, 2025	-3,336,800,000
Dec 31, 2024	-2,200,500,000
Sep 30, 2024	-1,511,100,000
Jun 30, 2024	-1,284,400,000
Mar 31, 2024	-1,420,500,000
Dec 31, 2023	-1,790,100,000
Sep 30, 2023	-1,591,600,000
Jun 30, 2023	-1,909,300,000
Mar 31, 2023	-1,396,200,000
Dec 31, 2022	-1,009,000,000
Sep 30, 2022	-1,668,000,000
Jun 30, 2022	-557,600,000
Mar 31, 2022	-574,700,000
Dec 31, 2021	-1,005,800,000
Sep 30, 2021	-404,500,000
Jun 30, 2021	-177,900,000
Mar 31, 2021	-2,672,500,000
Dec 31, 2020	-1,970,500,000
Sep 30, 2020	-2,010,900,000
Jun 30, 2020	-2,633,900,000
Mar 31, 2020	-36,400,000
Dec 31, 2019	-252,100,000
Sep 30, 2019	10,566,000
Jun 30, 2019	25,280,000
Mar 31, 2019	29,373,000
Dec 31, 2018	-77,100,000
Sep 30, 2018	-204,601,000
Jun 30, 2018	-216,511,000
Mar 31, 2018	-71,785,000
Dec 31, 2017	-24,400,000
Sep 30, 2017	-305,544,000
Jun 30, 2017	-268,673,000
Mar 31, 2017	-433,387,000
Dec 31, 2016	-700,391,000
Sep 30, 2016	-212,720,000
Jun 30, 2016	-587,044,000
Mar 31, 2016	-559,384,000
Dec 31, 2015	-262,796,000
Sep 30, 2015	-511,551,000
Jun 30, 2015	-160,736,000
Mar 31, 2015	-237,213,000
Dec 31, 2014	-218,655,000
Sep 30, 2014	139,672,000
Jun 30, 2014	138,039,000
Mar 31, 2014	174,570,000
Dec 31, 2013	77,139,000
Sep 30, 2013	-101,435,000
Jun 30, 2013	-106,777,000
Mar 31, 2013	-68,373,000
Dec 31, 2012	-97,646,000
Sep 30, 2012	336,804,000
Jun 30, 2012	338,334,000
Mar 31, 2012	353,462,000
Dec 31, 2011	384,249,000
Sep 30, 2011	205,568,000
Jun 30, 2011	207,460,000
Mar 31, 2011	200,128,000
Dec 31, 2010	243,306,000
Sep 30, 2010	82,875,000
Jun 30, 2010	83,410,000
Mar 31, 2010	86,540,000
Dec 31, 2009	31,363,000
Sep 30, 2009	-106,684,000
Jun 30, 2009	-107,508,000
Mar 31, 2009	-193,723,000
Dec 31, 2008	-192,858,000
Sep 30, 2008	237,090,000
Jun 30, 2008	236,113,000
Mar 31, 2008	319,345,000
Dec 31, 2007	319,400,000
Sep 30, 2007	185,296,000
Jun 30, 2007	186,019,000
Mar 31, 2007	183,940,000
Dec 31, 2006	185,398,000
Sep 30, 2006	8,232,000
Jun 30, 2006	7,252,000
Mar 31, 2006	6,467,000
Dec 31, 2005	4,081,000
Sep 30, 2005	1,941,000
Jun 30, 2005	1,043,000
Mar 31, 2005	1,370,000
Dec 31, 2004	4,441,000
Sep 30, 2004	8,210,000
Jun 30, 2004	58,541,000
Mar 31, 2004	63,788,000
Dec 31, 2003	108,184,000
Sep 30, 2003	104,190,000
Jun 30, 2003	54,619,000
Mar 31, 2003	49,163,000
Dec 31, 2002	1,723,000
Sep 30, 2002	192,409,000
Jun 30, 2002	192,855,000
Mar 31, 2002	196,025,000
Dec 31, 2001	349,120,000
Sep 30, 2001	157,679,000